1. Home
  2. NUVB vs GTY Comparison

NUVB vs GTY Comparison

Compare NUVB & GTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUVB
  • GTY
  • Stock Information
  • Founded
  • NUVB 2018
  • GTY 1955
  • Country
  • NUVB United States
  • GTY United States
  • Employees
  • NUVB N/A
  • GTY N/A
  • Industry
  • NUVB Biotechnology: Pharmaceutical Preparations
  • GTY Real Estate
  • Sector
  • NUVB Health Care
  • GTY Finance
  • Exchange
  • NUVB Nasdaq
  • GTY Nasdaq
  • Market Cap
  • NUVB 1.6B
  • GTY 1.5B
  • IPO Year
  • NUVB N/A
  • GTY N/A
  • Fundamental
  • Price
  • NUVB $4.62
  • GTY $27.32
  • Analyst Decision
  • NUVB Strong Buy
  • GTY Buy
  • Analyst Count
  • NUVB 7
  • GTY 5
  • Target Price
  • NUVB $8.86
  • GTY $31.80
  • AVG Volume (30 Days)
  • NUVB 9.4M
  • GTY 339.1K
  • Earning Date
  • NUVB 11-03-2025
  • GTY 10-22-2025
  • Dividend Yield
  • NUVB N/A
  • GTY 7.10%
  • EPS Growth
  • NUVB N/A
  • GTY 10.25
  • EPS
  • NUVB N/A
  • GTY 1.28
  • Revenue
  • NUVB $26,748,000.00
  • GTY $214,194,000.00
  • Revenue This Year
  • NUVB $283.17
  • GTY $4.37
  • Revenue Next Year
  • NUVB $340.98
  • GTY $12.39
  • P/E Ratio
  • NUVB N/A
  • GTY $21.39
  • Revenue Growth
  • NUVB 1137.19
  • GTY 8.17
  • 52 Week Low
  • NUVB $1.54
  • GTY $25.39
  • 52 Week High
  • NUVB $5.55
  • GTY $33.85
  • Technical
  • Relative Strength Index (RSI)
  • NUVB 55.23
  • GTY 48.97
  • Support Level
  • NUVB $4.45
  • GTY $26.97
  • Resistance Level
  • NUVB $5.17
  • GTY $27.50
  • Average True Range (ATR)
  • NUVB 0.44
  • GTY 0.54
  • MACD
  • NUVB -0.05
  • GTY -0.04
  • Stochastic Oscillator
  • NUVB 44.17
  • GTY 14.86

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

About GTY Getty Realty Corporation

Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.

Share on Social Networks: